Quality of tuberculosis care in the private health sector.

Public-private mix Quality care

Journal

Journal of clinical tuberculosis and other mycobacterial diseases
ISSN: 2405-5794
Titre abrégé: J Clin Tuberc Other Mycobact Dis
Pays: England
ID NLM: 101682877

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 10 7 2020
Statut: epublish

Résumé

As countries move towards achieving universal health coverage, efforts to engage all care providers have gained more significance. Over a third of people estimated to have developed TB in 2018 were not detected and notified by national TB programs (NTPs). This gap is more pronounced in countries with large private sectors, especially those with a high burden of TB. Health care providers outside the scope of NTPs, including the private and informal sector, are often the first point of care for TB patients. However, these providers are not fully engaged despite evidence from country experiences and projects that demonstrate increased detection and good treatment outcomes through publicprivate mix (PPM) approaches. While there are often concerns about quality of care in public facilities, there is also increasing evidence that quality of TB care in the private sector falls short of international standards in many places and urgently needs improvement. Failure to engage the full range of health care providers for TB has serious consequences in terms of access to quality care, resulting in increased transmission as a result of delayed diagnosis and treatment; excess mortality and morbidity as a result of inappropriate treatment; and increased drug resistance as a result of incomplete treatment. Recent attention to this issue has led to significant increases in private TB notifications, especially in India, Indonesia and the Philippines, but the gap between notification and the extension of quality program services for provision of treatment and care appears to be growing.

Identifiants

pubmed: 32642560
doi: 10.1016/j.jctube.2020.100171
pii: S2405-5794(20)30035-8
pii: 100171
pmc: PMC7332523
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100171

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 The Authors.

Références

PLoS Med. 2015 Jun 23;12(6):e1001842
pubmed: 26103555
Bull World Health Organ. 2006 Jun;84(6):437-45
pubmed: 16799727
Bull World Health Organ. 2006 Nov;84(11):876-83
pubmed: 17143461
BMJ. 2006 Mar 11;332(7541):574-8
pubmed: 16467347
Lancet Infect Dis. 2016 Nov;16(11):1255-1260
pubmed: 27568356
Int J Infect Dis. 2015 May;34:20-32
pubmed: 25722284
PLoS Med. 2018 Sep 25;15(9):e1002653
pubmed: 30252849
J Infect Dis. 2017 Nov 6;216(suppl_7):S686-S695
pubmed: 29117351
Lancet Glob Health. 2019 May;7(5):e585-e595
pubmed: 30904521
PLoS One. 2011 May 04;6(5):e18964
pubmed: 21573227
Int J Equity Health. 2011 Nov 10;10:49
pubmed: 22074377
PLoS Med. 2017 Oct 17;14(10):e1002405
pubmed: 29040263
Eur Respir J. 2014 Jun;43(6):1763-75
pubmed: 24525439
Int J Infect Dis. 2017 Mar;56:111-116
pubmed: 27794468
BMJ Glob Health. 2017 Jun 10;2(2):e000333
pubmed: 29225937

Auteurs

Guy Stallworthy (G)

Global TB Programme, World Health Organization, Geneva, Switzerland.

Hannah Monica Dias (HM)

Global TB Programme, World Health Organization, Geneva, Switzerland.

Madhukar Pai (M)

McGill International TB Centre, McGill University, Montreal, Canada.

Classifications MeSH